← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2006Last known activity
Aug 31, 2024
Timeline
1990s
- Jun 1, 1999
CTI Clinical Trial and Consulting Services— Founded
Drugs by trial phase (22 distinct, 30 trials)
Phase 3 (5 own, 0 via acquisition)
Phase 2 (10 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
- Acidosis
- Acidosis, Renal Tubular
- Adenocarcinoma
- Carcinoma, Ovarian Epithelial
- Congenital Abnormalities
- Delayed Graft Function
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Heart Failure
- Hepatitis
- Hepatitis A
- Hepatitis, Alcoholic
- Kidney Diseases
- Liver Failure
- Mesothelioma
- Mucopolysaccharidoses
- Mucopolysaccharidosis III
- Neoplasms
- Pneumonia
- Renal Insufficiency
- Renal Insufficiency, Chronic
- Syndrome
Recent trials (31)
- NCT06343792CollaboratorPhase 2Aug 31, 2024
- NCT05665166CollaboratorPhase 1/Phase 2Feb 28, 2023
- NCT05322590CollaboratorPhase 1/Phase 2Nov 30, 2022
- NCT05291286CollaboratorEarly Phase 1Oct 17, 2022
- NCT05253105CollaboratorPhase 1Mar 15, 2022
- NCT04771897CollaboratorPhase 1May 24, 2021
- NCT04563026CollaboratorPhase 2Oct 31, 2020
- NCT04563026Study directorPhase 2Oct 31, 2020
- NCT04540120CollaboratorPhase 2Sep 25, 2020
- NCT04459676CollaboratorPhase 2Jul 31, 2020
- NCT04404569CollaboratorPhase 1May 31, 2020
- NCT04201405CollaboratorPhase 1/Phase 2Dec 15, 2019
- NCT04137900CollaboratorPhase 1Oct 31, 2019
- NCT04115345CollaboratorPhase 1Aug 13, 2019
- NCT03967093CollaboratorPhase 1Apr 15, 2019
Details
- Founded
- Covington, KY, US Jun 1, 1999
- Last known activity
- Aug 31, 2024
Notes
CRO